1-4 of 4
Baerbel Schurich, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Influence of Renal Impairment and Genetic Risk Factors on Response to Induction Therapy in the HD4 and MM5 Trials of the GMMG

Christof Scheid, MDPhD, Thomas Hielscher, Uta Bertsch, MD, Christina Kunz, PhD, Hans Salwender, MD, Mathias Haenel, Maximilian Merz, Elias Karl Mai, MD, Dirk Hose, MD PhD, Baerbel Schurich, PhD, Markus Munder, MD, Ingo Schmidt-Wolf, MD, Christian Gerecke, MD, Walter Lindemann, MD, Matthias Zeis, MD, Katja Weisel, MD, Jan Duerig, MD, Anna Jauch, PhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2014) 124 (21): 4777.
https://doi.org/10.1182/blood.V124.21.4777.4777
Published: 2014
Journal Articles

Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma – Subgroup Analysis from the GMMG-MM5 Trial

Maximilian Merz, MD, Hans Salwender, MD, Mathias Hänel, MD, Uta Bertsch, MD, Christina Kunz, PhD, Thomas Hielscher, Igor W. Blau, MD, Christof Scheid, MDPhD, Elias Karl Mai, MD, Dirk Hose, MD, Baerbel Schurich, PhD, Markus Munder, MD, Ingo GH Schmidt-Wolf, MD, Christian Gerecke, MD, Hans Walter Lindemann, MD, Matthias Zeis, MD, Katja Weisel, MD, Jan Duerig, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2014) 124 (21): 3475.
https://doi.org/10.1182/blood.V124.21.3475.3475
Published: 2014
Journal Articles

Prognostic Value Of sFLC Ratio At Baseline On Response After Induction Therapy In Patients With Multiple Myeloma In The GMMG MM5 Trial

Mabast Moohialdin, Hans Salwender, MD, Uta Bertsch, MD, Jan Duerig, MD, Christina Kunz, PhD, Thomas Hielscher, Markus Zorn, Mathias Haenel, MD, Igor Wolfgang Blau, MD, PhD, Dirk Hose, Dr. med. dipl.-phys, Baerbel Schurich, PhD, Kai Neben, MD, Anja Seckinger, MD, Markus Munder, MD, Walter Lindemann, MD, Matthias Zeis, MD, Christian Gerecke, MD, Ingo GH Schmidt-Wolf, MD, Katja Weisel, MD, Christof Scheid, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2013) 122 (21): 1897.
https://doi.org/10.1182/blood.V122.21.1897.1897
Published: 2013
Journal Articles

GMMG MM5 Trial In Newly Diagnosed Multiple Myeloma To Evaluate PAd Vs VCD Induction Prior To High Dose Treatment Followed By Lenalidomide Consolidation and Maintenance – Final Analysis On Induction Therapy

Hartmut Goldschmidt, MD, Jan Duerig, MD, Uta Bertsch, MD, Christina Kunz, PhD, Thomas Hielscher, Mathias Haenel, MD, Igor Wolfgang Blau, MD, PhD, Dirk Hose, Dr. med. dipl.-phys, Anna Jauch, PhD, Baerbel Schurich, PhD, Kai Neben, MD, Anja Seckinger, MD, Barbara Huegle-Doerr, PhD, Maximilian Merz, MD, Markus Munder, MD, Walter Lindemann, MD, Matthias Zeis, MD, Christian Gerecke, MD, Ingo GH Schmidt-Wolf, MD, Katja Weisel, MD, Christof Scheid, MD, Hans Salwender, MD
Journal: Blood
Blood (2013) 122 (21): 3369.
https://doi.org/10.1182/blood.V122.21.3369.3369
Published: 2013